“Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 and 2 and ADOL)”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s48, https://doi.org/10.25251/skin.4.supp.47.